You are here

  • Home
  • Archive
  • Volume 66, Issue 12
  • Continuous subcutaneous insulin infusion (CSII) does not prevent progression of proliferative and preproliferative retinopathy.

Article info

Article menu
Download PDFPDF
Research Article
Continuous subcutaneous insulin infusion (CSII) does not prevent progression of proliferative and preproliferative retinopathy.

Authors

Citation

Lawson PM, Champion MC, Canny C, et al
Continuous subcutaneous insulin infusion (CSII) does not prevent progression of proliferative and preproliferative retinopathy.
British Journal of Ophthalmology 1982;66:762-766.
Online issue publication 
February 23, 2017

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.